Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse (Q37287549)
Jump to navigation
Jump to search
scientific article published on 14 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse |
scientific article published on 14 July 2009 |
Statements
1 reference
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse (English)
1 reference
C Kahlert
1 reference
H Weber
1 reference
C Mogler
1 reference
F Bergmann
1 reference
P Schirmacher
1 reference
H G Kenngott
1 reference
U Matterne
1 reference
N Mollberg
1 reference
N N Rahbari
1 reference
U Hinz
1 reference
M Koch
1 reference
M Aigner
1 reference
J Weitz
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference